|
PEAR
|
Pear Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
US
|
NYSE
|
|
PHGE
|
BiomX Inc.
|
US
|
AMEX
|
|
PKI
|
PerkinElmer, Inc.
|
US
|
NYSE
|
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|
|
PRME
|
Prime Medicine, Inc.
|
US
|
NASDAQ
|
|
PRPO
|
Precipio, Inc.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PSTV
|
Plus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTN
|
Palatin Technologies, Inc.
|
US
|
AMEX
|
|
PTPI
|
Petros Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
QIPT
|
Quipt Home Medical Corp.
|
US
|
NASDAQ
|
|
QLGN
|
Qualigen Therapeutics, Inc.
|
US
|
NASDAQ
|
|
QLI
|
Qilian International Holding Group Ltd.
|
US
|
NASDAQ
|
|
QNCX
|
Quince Therapeutics, Inc.
|
US
|
NASDAQ
|
|
QTRX
|
Quanterix Corporation
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
US
|
NASDAQ
|